Mandatory Future Reexaminations
In only certain cases will the VA conduct reexaminations to assess the current severity of a veteran's service-connected disabilities. The purpose of these reexaminations being to ensure that disability ratings accurately reflect any changes in the condition over time. HOWEVER, MOST CONDITIONS do NOT require future evaluations!
On October 7, 2021, VA Policy Letter 21-01 updated and clarified policy surrounding when routine future examinations (RFE). In short boiling down to mandatory reexaminations being limited (in MOST cases) to when a VA regulation requires it. If a rater wants to add a reevaluation otherwise the particular evidence justifying it must be EXCEPTIONALLY COMPELLING or needed to properly evaluate the Veteran!
There are 4 primary cases in which a rater will establish an RFE:
When mandated by the Rating schedule;
After award of temporary 100% due to Hospitalization AND evidence suggests improvement of condition;
After award of temporary 100% due to Convalescence AND evidence does not show severity afterwards or suggests improvement; or
Prestabilization rating for specific conditions from a MEDBOARD separation ONLY.
When a rater awards an extra-scheduler 50 or 100% evaluation (rating schedule does not have a 50 or 100% rating for the condition); or
Service-connection is granted for a Mental condition related to trauma.
The 4th case is when there is EXTREMELY COMPELLING evidence the condition is likely to improve. This case is so rare in practice that MOST RATERS are just gonna label the condition as static and walk away.
When the Rater is Expressly PROHIBITED from Establishing a Reevaluation
Condition is static (disability is permanent in character and of such nature that there is no likelihood of improvement);
Findings and symptoms are shown to have persisted without material improvement over five years or more;
Veteran is over 55 years of age (except under unusual circumstances);
Evaluation is the lowest stated evaluation for the condition in the rating schedule;
Evaluation is 10% or less; or
Combined evaluation would not change even if the reexamination resulted in a reduced evaluation for one or more disabilities.
IMPORTANT NOTE:
Regulatory requirements for a reexamination DO override these prohibitions!
Penalties for Failure to Attend Scheduled Reexaminations
Attendance at these exams is REQUIRED! Failure to report without good cause may result in reduction (after appropriate Due process) to 0%, the minimum evaluation for the condition, or based upon recent evidence of record; whichever is highest.
IMPORTANT NOTES:
Protection via the 5 year rule does NOT apply!
Protection via the 20 year rule overrides and the condition CANNOT be reduced!
Conditions with Regulatory Required Future Reexaminations
The following table lists what conditions are mandated by regulation to have a reevaluation. Meaning, unless your condition is one of the following AND meets the specifics, your condition is VERY LIKELY static.
IMPORTANT NOTES:
In the cases of cancers, if the cancer is terminal (as noted by a doctor or the evidence of record (entered palliative care or cancer is spreading)) the condition will be made static and no further examinations will be set up for the cancer(s).
For situations in which (how could a rater know somethings ends/resolves), the examiner will generally note when expected treatments will end/condition will resolve. If a Veteran refuses/is not taking cancer or other treatment(s) or the examiner does not provide an expected time frame - then the rater will typically assign a reevaluation between 6 months to 3 years.
NOTE:
For specifics details of what is considered appropriate treatment, etc. click on the specific condition.
Condition | Reevaluation |
---|---|
≥6 month Hospitalization for mental | 6 months after release |
Prestablized medboard conditions | 6-12 months after separation |
Acquired hemolytic anemia | 6 months after release |
Agranculocytosis | 6 months after release |
Aortic aneurysm | 6 months after release |
Aplastic anemia | 6 months after treatment/release |
Breast cancer | 6 months after treatment/remission |
Chronic liver disease | 6 months after treatment |
Chronic myelogenous leukemia | 6 months after treatment |
Digestive cancer | 6 months after treatment/remission |
Ear cancer | 6 months after treatment/remission |
Endocrine cancer | 6 months after treatment/remission |
Essential thrombocythemia | 6 months after treatment/release |
Eye cancer | 6 months after treatment/remission |
Genitourinary cancer | 6 months after treatment/remission |
Gynecological cancer | 6 months after treatment/remission |
Heart transplant | 1 year after release |
Heart valve replacement | 6 months after release |
Hodgkin's Lymphoma | 6 months after treatment/remission |
Hyperinfection Syndrome | Immediately after going inactive |
Hyperparathyroidism | 6 months after release/treatment |
Hypothyroidism | 6 months after release |
Immune thrombocytpenia | 6 months after treatment |
Kidney transplant | 1 year after release |
Large artery aneurysm | 6 months after release |
Leukemia | 6 months after treatment |
Leprosy | 6 months after treatment/remission |
Liver abscess | 6 months after original diagnosis |
Liver transplant | 1 year after release |
Malignant melanoma | 6 months after treatment/remission |
Multiple myeloma | 5 years after treatment/remission |
Muscle cancer | 6 months after treatment/remission |
Myelodysplastic syndromes | 6 months after treatment/release |
Non-Hodgkin's lymphoma | 2 years after treatment/remission |
NonTB mycobacterium infection | Immediately after going inactive |
Oral cancer | 6 months after treatment/remission |
Pancreas transplant | 1 year release |
Pernicious anemia | 6 months after treatment/release |
Peptic ulcer | 3 months after surgery/release |
Polycythemia vera | 6 months after treatment/release |
Primary myelofibrosis | 6 months after treatment/release |
Rectum prolaspse | 2 months after repair |
Respiratory cancer | 6 months after treatment/remission |
Skin cancer | 6 months after treatment/remission |
Soft tissue sarcoma (other) | 6 months after treatment/remission |
Soft tissue sarcoma (vascular) | 6 months after treatment/remission |
Solitary plasmacytoma | 6 months after treatment/remission |
Tuberculosis | Immediately after going inactive |
Ventricular arrhythmias | 6 months after release |
Visceral leishmaniasis | 6 months after treatment/remission |
At Once Examination
Unlike future reexamination; done several months to years after a decision, these examinations are typically ordered immediately after the decision is made. In practice this is a RARELY done, as most raters will simply defer for an examination or opinion and keep the current claim running.
The M21 specifically states an at-once examination should be input when:
Rater grants temporary 100% based on convalescence AND rating was made before end of the temporary 100% period;
Medboard indicates entitlement to Special Monthly Compensation (SMC) but evidence is not sufficient; or
Medical record shows Kidney function rates at least 10% but the record does not show a full 3 month period over a 12 month span showing that same level of kidney function.
Frequently Asked Questions
-
In those cases, the rating schedule does not mandate a future evaluation after an established period of 100%. After which the condition reduces to a set minimum evaluation. Meaning if the Veteran wants to file an increase they can do so. However, a rater CAN still schedule a reevaluation even if not mandatory.
-
-
When is the date of the examination?
If it is years in the past then the VA lost track of things at some point. If a reexamination was noted based on the prior rater’s opinion and not regulation, a new rater may simply remove it and drive on. Otherwise the VA (once told) will order the reexamination.
If it is in the future then you should expect that reexamination. If you are still within a year of the decision you may file a Higher level review to address the matter. Past the year there is no mechanism to fix it. Outside of that you would need to declare a CUE (which may ironically cause you to go to a new exam) or filing an increase (which WILL cause a new exam).
-
Veterans can continue to have reevaluations for cancer up to 20 YEARS (if evaluated at the 100% rate the whole time), if the condition is not made permanent sooner.
References
38 CFR § 3.655 - Failure to report for Department of Veterans Affairs examination
38 CFR § 4.28 - Prestabilization rating from date of discharge from service
38 CFR § 4.128 - Convalescence ratings following extended hospitalization
M21-1, Part IV, Subpart ii, Chapter 1, Section A - Determining the Need for Review Examinations
M21-1, Part IV, Subpart ii, Chapter 1, Section B - Control of Future Examinations
M21-1, Part IV, Subpart ii, Chapter 2, Section B - Failure to Report for Review Examinations
M21-1, Part V, Subpart iii, Chapter 7 - Genitourinary Disabilities
M21-1, Part VIII, Subpart iv, Chapter 8, Section A - Prestabilization Ratings Under 38 CFR 4.28
M21-1, Part VIII, Subpart iv, Chapter 8, Section B - Hospitalization Ratings Under 38 CFR 4.29
M21-1, Part VIII, Subpart iv, Chapter 8, Section C - Convalescent Ratings Under 38 CFR 4.30